Abstract:Background: White matter hyperintensities of presumed vascular origin (WMH) are the most prominent imaging feature of cerebral small vessel disease (cSVD). Previous studies suggest a link between cSVD burden and intracerebral hemorrhage and worse functional outcome after thrombolysis in acute ischemic stroke. We aimed to determine the impact of WMH burden on efficacy and safety of thrombolysis in the MRI-based randomized controlled WAKE-UP trial of intravenous alteplase in unknown onset stroke. Methods: The design of this post hoc study was an observational cohort design of a secondary analysis of a randomized trial. WMH volume was quantified on baseline fluid-attenuated inversion recovery images of patients randomized to either alteplase or placebo in the WAKE-UP trial. Excellent outcome was defined as score of 0-1 on the modified Rankin Scale after 90 days. Hemorrhagic transformation was assessed on follow-up imaging 24-36 hours after randomization. Treatment effect and safety were analyzed by fitting multivariable logistic regression models. Results: Quality of scans was sufficient in 441 of 503 randomized patients to delineate WMH. Median age was 68 years, 151 patients were female, and 222 patients were assigned to receive alteplase. Median WMH volume was 11.4 mL. Independent from treatment, WMH burden was statistically significantly associated with worse functional outcome (odds ratio, 0.72 [95% CI, 0.57-0.92]), but not with higher chances of any hemorrhagic transformation (odds ratio, 0.78 [95% CI, 0.60-1.01]). There was no interaction of WMH burden and treatment group for the likelihood of excellent outcome (P=0.443) or any hemorrhagic transformation (P=0.151). In a subgroup of 166 patients with severe WMH, intravenous thrombolysis was associated with higher odds of excellent outcome (odds ratio, 2.40 [95% CI, 1.19-4.84]) with no significant increase in the rate of hemorrhagic transformation (odds ratio, 1.96 [95% CI, 0.80-4.81]). Conclusions: Although WMH burden is associated with worse functional outcome, there is no association with treatment effect or safety of intravenous thrombolysis in patients with ischemic stroke of unknown onset. Registration: URL: https://www. Clinicaltrials: gov; Unique identifier: NCT01525290.

Abstract WP186: The Burden of White Matter Hyperintensities on Function Outcomes in Patients Treated for Acute Ischemic Stroke: A Post-Hoc Analysis of the IMS-III Trial

Relationship Between White-Matter Hyperintensities and Hematoma Volume and Growth in Patients with Intracerebral Hemorrhage

Global White Matter Hypoperfusion on CT Predicts Larger Infarcts and Hemorrhagic Transformation after Acute Ischemia.

Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis.

Abstract W P43: Extent of “blooming Effect” Predicts Middle Cerebral Artery Recanalization after Intravenous Thrombolysis

[Impact of Cerebral Microbleeds on Outcomes of Acute Ischemic Stroke Treated with Intravenous Thrombolysis].

Excessive White Matter Hyperintensity Increases Susceptibility to Poor Functional Outcomes After Acute Ischemic Stroke

Abstract TP166: White Matter Hyperintensity Burden Associated With Stroke Severity, Aphasia, and Motor Deficits During Intracerebral Hemorrhage Hospitalization

Effects of white matter hyperintensity burden on functional outcome after mild versus moderate-to-severe ischemic stroke

The efficacy of intravenous thrombolysis in acute ischemic stroke patients with white matter hyperintensity

White matter hyperintensities rather than the overall burden of cerebral small vessel disease is correlated with the outcomes in patients with acute ischemic stroke

Abstract WMP15: Do Changes in Blood Brain Barrier Permeability Mediate the Association Between White Matter Hyperintensities and Post-Stroke Clinical Outcome?

Intravenous Thrombolysis in Patients With White Matter Hyperintensities in the WAKE-UP Trial

The Relationship Between T2 White-Matter Hyperintensities and Hemorrhagic Transformation and Neurological Outcome after Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

White Matter Hyperintensity, Immediate Antihypertensive Treatment, and Functional Outcome after Acute Ischemic Stroke

White Matter Hyperintensity is Associated with Malignant Cerebral Edema in Ischemic Stroke Treated with Thrombectomy

White Matter Hyperintensity Volume and Poststroke Cognition: An Individual Patient Data Pooled Analysis of 9 Ischemic Stroke Cohort Studies

Cerebral computed tomography-graded white matter lesions are associated with worse outcome after thrombolysis in patients with stroke

White matter hyperintensities as a predictor of aphasia recovery

Abstract TP182: Vessel Wall MRI in Diagnosis and Prognosis of Intracranial Vasculopathy

Modulation of the Association Between Corticospinal Tract Damage and Outcome After Stroke by White Matter Hyperintensities